Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
01 2020
Historique:
received: 29 10 2019
accepted: 12 11 2019
pubmed: 18 12 2019
medline: 9 4 2020
entrez: 18 12 2019
Statut: ppublish

Résumé

Extrachromosomal circularization of DNA is an important genomic feature in cancer. However, the structure, composition and genome-wide frequency of extrachromosomal circular DNA have not yet been profiled extensively. Here, we combine genomic and transcriptomic approaches to describe the landscape of extrachromosomal circular DNA in neuroblastoma, a tumor arising in childhood from primitive cells of the sympathetic nervous system. Our analysis identifies and characterizes a wide catalog of somatically acquired and undescribed extrachromosomal circular DNAs. Moreover, we find that extrachromosomal circular DNAs are an unanticipated major source of somatic rearrangements, contributing to oncogenic remodeling through chimeric circularization and reintegration of circular DNA into the linear genome. Cancer-causing lesions can emerge out of circle-derived rearrangements and are associated with adverse clinical outcome. It is highly probable that circle-derived rearrangements represent an ongoing mutagenic process. Thus, extrachromosomal circular DNAs represent a multihit mutagenic process, with important functional and clinical implications for the origins of genomic remodeling in cancer.

Identifiants

pubmed: 31844324
doi: 10.1038/s41588-019-0547-z
pii: 10.1038/s41588-019-0547-z
pmc: PMC7008131
mid: NIHMS1066833
doi:

Substances chimiques

DNA, Circular 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-34

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Turner, K. M. et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543, 122–125 (2017).
doi: 10.1038/nature21356
Møller, H. D. et al. Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. Nat. Commun. 9, 1069 (2018).
doi: 10.1038/s41467-018-03369-8
Shibata, Y. et al. Extrachromosomal microDNAs and chromosomal microdeletions in normal tissues. Science 336, 82–86 (2012).
doi: 10.1126/science.1213307
Pennisi, E. Circular DNA throws biologists for a loop. Science 356, 996 (2017).
doi: 10.1126/science.356.6342.996
Verhaak, R. G. W., Bafna, V. & Mischel, P. S. Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.Nat. Rev. Cancer 19, 283–288 (2019).
doi: 10.1038/s41568-019-0128-6
Møller, H. D., Parsons, L., Jørgensen, T. S., Botstein, D. & Regenberg, B. Extrachromosomal circular DNA is common in yeast. Proc. Natl Acad. Sci. USA 112, E3114–E3122 (2015).
doi: 10.1073/pnas.1508825112
Tjio, J. H. & Levan, A. The chromosome number of man. Hereditas 42, 1–6 (1956).
doi: 10.1111/j.1601-5223.1956.tb03010.x
Garsed, D. W. et al. The architecture and evolution of cancer neochromosomes. Cancer Cell 26, 653–667 (2014).
doi: 10.1016/j.ccell.2014.09.010
Rausch, T. et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148, 59–71 (2012).
doi: 10.1016/j.cell.2011.12.013
Kohl, N. E. et al. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35, 359–367 (1983).
doi: 10.1016/0092-8674(83)90169-1
deCarvalho, A. C. et al. Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma. Nat. Genet. 50, 708–717 (2018).
doi: 10.1038/s41588-018-0105-0
Nikolaev, S. et al. Extrachromosomal driver mutations in glioblastoma and low-grade glioma. Nat. Commun. 5, 5690 (2014).
doi: 10.1038/ncomms6690
Schwab, M. et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305, 245–248 (1983).
doi: 10.1038/305245a0
Balaban-Malenbaum, G. & Gilbert, F. Double minute chromosomes and the homogeneously staining regions in chromosomes of a human neuroblastoma cell line. Science 198, 739–741 (1977).
doi: 10.1126/science.71759
Cox, D., Yuncken, C. & Spriggs, A. I. Minute chromatin bodies in malignant tumours of childhood. Lancet 1, 55–58 (1965).
doi: 10.1016/S0140-6736(65)90131-5
Sanborn, J. Z. et al. Double minute chromosomes in glioblastoma multiforme are revealed by precise reconstruction of oncogenic amplicons. Cancer Res. 73, 6036–6045 (2013).
doi: 10.1158/0008-5472.CAN-13-0186
Deshpande, V. et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat. Commun. 10, 392 (2019).
doi: 10.1038/s41467-018-08200-y
Avet-Loiseau, H. et al. Morphologic and molecular cytogenetics in neuroblastoma. Cancer 75, 1694–1699 (1995).
doi: 10.1002/1097-0142(19950401)75:7<1694::AID-CNCR2820750721>3.0.CO;2-Z
Dillon, L. W. et al. Production of extrachromosomal microDNAs is linked to mismatch repair pathways and transcriptional activity. Cell Rep. 11, 1749–1759 (2015).
doi: 10.1016/j.celrep.2015.05.020
Forbes, S. A. et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 45, D777–D783 (2017).
doi: 10.1093/nar/gkw1121
Bouzas-Rodriguez, J. et al. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J. Clin. Invest. 120, 850–858 (2010).
doi: 10.1172/JCI41013
Xu, K. Structure and evolution of double minutes in diagnosis and relapse brain tumors. Acta Neuropathol. 137, 123–137 (2019).
doi: 10.1007/s00401-018-1912-1
Storlazzi, C. T. et al. Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res. 20, 1198–1206 (2010).
doi: 10.1101/gr.106252.110
Villamón, E. et al. Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion. PLoS ONE 8, e53740 (2013).
doi: 10.1371/journal.pone.0053740
Marrano, P., Irwin, M. S. & Thorner, P. S. Heterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis. Genes Chromosomes Cancer 56, 28–41 (2017).
doi: 10.1002/gcc.22398
Gröbner, S. N. et al. The landscape of genomic alterations across childhood cancers. Nature 555, 321–327 (2018).
doi: 10.1038/nature25480
Northcott, P. A. et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511, 428–434 (2014).
doi: 10.1038/nature13379
Henssen, A. G. et al. PGBD5 promotes site-specific oncogenic mutations in human tumors. Nat. Genet. 49, 1005–1014 (2017).
doi: 10.1038/ng.3866
Henssen, A. G. et al. Genomic DNA transposition induced by human PGBD5. eLife 4, e10565 (2015).
doi: 10.7554/eLife.10565
Henssen, A. G. et al. Forward genetic screen of human transposase genomic rearrangements. BMC Genomics 17, 548 (2016).
doi: 10.1186/s12864-016-2877-x
Guzmán, C., Bagga, M., Kaur, A., Westermarck, J. & Abankwa, D. ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS ONE 9, e92444 (2014).
doi: 10.1371/journal.pone.0092444
Henssen, A. G., MacArthur, I., Koche, R. & Dorado-García, H. Purification and sequencing of large circular DNA from human cells. Protoc Exch (2019); https://doi.org/10.1038/protex.2019.006
Boeva, V. et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics 28, 423–425 (2012).
doi: 10.1093/bioinformatics/btr670
Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910–16915 (2010).
doi: 10.1073/pnas.1009843107
Chong, Z. et al. novoBreak: local assembly for breakpoint detection in cancer genomes. Nat. Methods 14, 65–67 (2017).
doi: 10.1038/nmeth.4084
Wala, J. A. et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res. 28, 581–591 (2018).
doi: 10.1101/gr.221028.117
Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333–i339 (2012).
doi: 10.1093/bioinformatics/bts378
Moncunill, V. et al. Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads. Nat. Biotechnol. 32, 1106–1112 (2014).
doi: 10.1038/nbt.3027
Helmsauer, K. Tree-shaped Rearrangement Patterns in Pediatric Cancer Genomes (2019); https://kons.shinyapps.io/trees
Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
doi: 10.1038/ng1180
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
doi: 10.1073/pnas.0506580102

Auteurs

Richard P Koche (RP)

Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kocher@mskcc.org.

Elias Rodriguez-Fos (E)

Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.

Konstantin Helmsauer (K)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Martin Burkert (M)

Department of Biology, Humboldt University, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.
Max Delbrück Center for Molecular Medicine, Berlin, Germany.

Ian C MacArthur (IC)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Jesper Maag (J)

Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Rocio Chamorro (R)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Natalia Munoz-Perez (N)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Montserrat Puiggròs (M)

Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.

Heathcliff Dorado Garcia (H)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Yi Bei (Y)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Claudia Röefzaad (C)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Victor Bardinet (V)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Annabell Szymansky (A)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Annika Winkler (A)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Theresa Thole (T)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Natalie Timme (N)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Katharina Kasack (K)

German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Steffen Fuchs (S)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Filippos Klironomos (F)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Nina Thiessen (N)

Berlin Institute of Health, Berlin, Germany.

Eric Blanc (E)

Berlin Institute of Health, Berlin, Germany.

Karin Schmelz (K)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Annette Künkele (A)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Patrick Hundsdörfer (P)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Carolina Rosswog (C)

German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jessica Theissen (J)

German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Dieter Beule (D)

Berlin Institute of Health, Berlin, Germany.

Hedwig Deubzer (H)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany.

Sascha Sauer (S)

Berlin Institute of Health, Berlin, Germany.

Joern Toedling (J)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Matthias Fischer (M)

Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany.

Falk Hertwig (F)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Roland F Schwarz (RF)

Max Delbrück Center for Molecular Medicine, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Angelika Eggert (A)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

David Torrents (D)

Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.

Johannes H Schulte (JH)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Anton G Henssen (AG)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany. henssenlab@gmail.com.
Berlin Institute of Health, Berlin, Germany. henssenlab@gmail.com.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. henssenlab@gmail.com.
Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany. henssenlab@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH